FDA
approval
· 2022-09-01
FDA Approved: SPEVIGO — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
Summary
FDA approved SPEVIGO (spesolimab-sbzo) from Boehringer Ingelheim in an original application for generalized pustular psoriasis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for SPEVIGO (SPESOLIMAB-SBZO)